Somnics Health has introduced a transformative offering in the sleep apnea market with the launch of iNAP Essentials, a program that delivers its innovative, mask-free sleep therapy for just $58 per month over 24 months—no insurance required. At the heart of this initiative is the iNAP Sleep Therapy System, an FDA-cleared, clinically validated device that uses gentle negative pressure to keep the airway open during sleep, eliminating the need for forced air, bulky masks, or noise. This marks a significant departure from conventional CPAP therapy, offering patients a discreet, comfortable, and travel-friendly alternative.
Designed for ease of use and daily integration, iNAP works by creating a light vacuum in the oral cavity to reposition soft tissues and prevent airway obstruction—making it effective for many patients with Obstructive Sleep Apnea (OSA). With over 50 million Americans affected by OSA and 80% remaining untreated or non-adherent to CPAP, the iNAP system presents a compelling solution. The iNAP Essentials package includes everything needed to begin therapy: the starter kit, initial supplies, a dedicated sleep coach, and access to the iNAP Sleep App for tracking and sharing data with providers. It empowers patients with flexibility, transparency, and professional guidance, without long-term commitments or hidden fees.
The launch of iNAP Essentials signifies more than just a pricing shift—it’s a step toward health equity and patient-centered care. By lowering financial barriers and offering a non-invasive, user-friendly option, Somnics Health is addressing key reasons for treatment avoidance and dropout in traditional OSA therapies. As sleep medicine evolves, iNAP is emerging as a viable first-line or alternative treatment, gaining traction among physicians and patients alike. In advancing comfort, adherence, and affordability, iNAP Essentials is helping reshape the future of sleep apnea care and improving health outcomes for a broader population.
MedTech Spectrum's Summary
Affordable Access to Innovation: iNAP Essentials makes FDA-cleared, mask-free OSA therapy accessible at just $58/month—removing cost and insurance barriers for millions of untreated or CPAP-intolerant patients.
Patient-Centered Design: The iNAP system offers a discreet, travel-friendly alternative to CPAP, with higher comfort and adherence—empowering patients to stay engaged with their therapy.
Advancing Health Equity: By lowering financial and usability barriers, Somnics Health is reshaping OSA treatment to be more inclusive, proactive, and aligned with modern patient needs.